Acarmet
AssetSmall moleculeAlso Metformin/Acarbose
Combination of metformin and acarbose to improve glycemic control by reducing glucose production and intestinal carbohydrate absorption.
- Stage
- Phase 3
- Modality
- Small molecule
- Target
- AMPK signalling
- Indications
- 4
- Trials
- 1,384
- Developers
- 1
Indications
4Plus acarbose 50 mg tablets thrice daily versus acarbose 50 mg thrice daily over 16 week in
Phase 3UNKNOWNNCT01245166clinicaltrials.gov7 Oct 2026
Subject with type 2 diabetes mellitus
Phase 3UNKNOWNNCT01245166clinicaltrials.gov7 Oct 2026
The objective of the study is to evaluate the efficacy and safety of acarmet metformin hcl 500 mg
Phase 3UNKNOWNNCT01245166clinicaltrials.gov7 Oct 2026
1 more
- Targets and what it contains5
- Owner and partners1
- Trials1,384
- Evidence for its targets4
- Competitors12
- Aging relevance3
- Signals15
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 5 sources